Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
20 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/metaba-and-max-biopharma-announce-breakthrough-progress-on-next-generation-oxysterol-based-antibiotics-302379559.html
24 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/max-biopharma-announces-key-update-on-its-anti-fibrotic-and-anti-inflammatory-oxysterol-drug-candidate-that-inhibits-mash-atherosclerosis-and-fat-tissue-inflammation-302285545.html
15 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/avirmax-biopharma-inc-to-exhibit-development-of-next-generation-gene-therapies-for-ocular-diseases-at-the-aao-2024-annual-meeting-in-chicago-302277135.html
26 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/max-biopharma-and-metaba-announce-collaboration-on-metabolomics-studies-302070283.html
13 Sep 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/max-biopharma-announces-publication-of-proof-of-principle-regarding-its-oxysterol-lead-drug-candidate-oxy210-that-inhibits-fatty-liver-and-fibrosis-in-a-humanized-mouse-model-301374743.html
02 Feb 2021
// BIOSPACE
https://www.biospace.com/article/releases/max-biopharma-announces-key-discoveries-regarding-oxysterol-drug-candidates-for-targeting-covid-19/
ABOUT THIS PAGE